Galectin Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.93

+0.03 (+0.77%)

As of Sep 28, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +229.8% upside

Low Target $9.51

Average Target $12.96

High Target $17.52

Current Price $3.93

Current
$3.93

Target
$12.96

$9.51 $12.96 avg $17.52

Scenario Analysis

Bear Case

$9.51

142.0%

Low target

Base Case

$12.96

+229.8%

Avg target

Bull Case

$17.52

+345.8%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$7.13

-44.9% from high

52-Week Low

$2.03

+94.1% from low

Target vs 52W High

$12.96

+81.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%